113522-59-1

Basic information

• Product Name: CH(CH₂CH₂OBn)(CO₂Me)2
• Synonyms: CH(CH₂CH₂OBn)(CO₂Me)2
• CAS NO: 113522-59-1
• Molecular Weight: 266.294
• Mol File: 113522-59-1.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: CH(CH₂CH₂OBn)(CO₂Me)2(CAS DataBase Reference)
• NIST Chemistry Reference: CH(CH₂CH₂OBn)(CO₂Me)2(113522-59-1)
• EPA Substance Registry System: CH(CH₂CH₂OBn)(CO₂Me)2(113522-59-1)

Safety Data

• Hazardous Substances Data: 113522-59-1(Hazardous Substances Data)

Upstream product

• 54555-84-9 benzyl iodoethyl ether 
• 108-59-8 malonic acid dimethyl ester 
• 936-51-6 2-phenyl-1,3-dioxolane 
• 622-08-2 2-Benzyloxyethanol 
• 1462-37-9 bromoethyl-2-benzyl ether 

Downstream Products

• 113522-64-8 2-[4-Benzyloxy-2-(tert-butyl-diphenyl-silanyloxymethyl)-butyl]-6,6-dimethyl-cyclohex-2-enone 
• 113522-63-7 2-[4-Benzyloxy-2-(tert-butyl-diphenyl-silanyloxymethyl)-butyl]-6,6-dimethyl-cyclohex-3-enone 
• 113522-72-8 4-(tert-Butyl-diphenyl-silanyloxy)-3-(5,5-dimethyl-6-oxo-cyclohex-1-enylmethyl)-butyric acid methyl ester 
• 113522-69-3 4-(tert-Butyl-diphenyl-silanyloxy)-3-(5,5-dimethyl-6-oxo-cyclohex-1-enylmethyl)-butyric acid 
• 113522-65-9 2-[2-(tert-Butyl-diphenyl-silanyloxymethyl)-4-hydroxy-butyl]-6,6-dimethyl-cyclohex-2-enone 
• 113522-61-5 (4-Benzyloxy-2-iodomethyl-butoxy)-tert-butyl-diphenyl-silane 
• 113522-71-7 4-(5,5-Dimethyl-6-oxo-cyclohex-1-enyl)-3-hydroxymethyl-butyric acid methyl ester 
• 113522-82-0 4-(5,5-Dimethyl-6-oxo-cyclohex-1-enyl)-3-formyl-butyric acid methyl ester 
• 113522-70-6 4-(5,5-Dimethyl-6-oxo-cyclohex-1-enyl)-3-hydroxymethyl-butyric acid 
• 113522-73-9 4-(5,5-Dimethyl-6-oxo-cyclohex-1-enylmethyl)-dihydro-furan-2-one 
• 77661-80-4 2-(2-(benzyloxy)ethyl)propane-1,3-diol 

Relevant articles and documents

A FORMAL TOTAL SYNTHESIS OF (+/-)-STRIGOL

A novel route to the tricyclic compound (+/-)-6, a known precursor to (+/-)-strigol is disclosed.

NOVEL PHARMACEUTICAL COMPRISING HETEROAROMATIC AMIDE DERIVATIVE OR SALT THEREOF

PROBLEM TO BE SOLVED: To provide a compound useful for treating or preventing disease associated with voltage-dependent sodium channel (Nav1.7) such as disease involving a pain, disease involving an itch, autonomic nerve-associated disease, or a pharmaceutical composition thereof. SOLUTION: The present disclosure provides a compound illustrated by the following formula, and a pharmaceutical composition containing the same. SELECTED DRAWING: None COPYRIGHT: (C)2021,JPOandINPIT